- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Medical Equipment/Devices
- Sub-Industry: Life Science Equipment
Snapshot for Illumina Inc (ILMN)
| Open: | 71.6900 | Day's Range: | 71.1700 - 72.3500 | Volume: | 237,523 |
|---|---|---|---|---|---|
| Previous Close: | 71.6900 | 52wk Range: | 38.3300 - 77.1100 | 1-Yr Rtn: | +72.78% |
Key Statistics for ILMN
| Current P/E Ratio (ttm) | 37.6958 |
|---|---|
| Estimated P/E(12/2013) | 42.7691 |
| Relative P/E vs. SPX | 2.3268 |
| Earnings Per Share (USD) (ttm) | 1.8970 |
| Est. EPS (USD) (12/2013) | 1.6720 |
| Est. PEG Ratio | 2.4460 |
| Market Cap (M USD) | 8,894.31 |
| Shares Outstanding (M) | 124.38 |
| 30 Day Average Volume | 1,433,272 |
| Price/Book (mrq) | 6.7592 |
| Price/Sale (ttm) | 7.2842 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 07/24/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for ILMN
Company Profile & Key Executives for ILMN
Illumina, Inc. develops, manufactures and markets integrated systems for the large scale analysis of genetic variation and biological function. The Company provides a comprehensive line of products and services that currently serve the sequencing, genotyping and gene expression markets for genomic research centers, pharmaceutical companies, academic institutions and biotechnology companies.
| Jay T FlatleyPresident/CEO | Marc A StapleySenior VP/CFO |
| Mostafa RonaghiSenior VP/CTO | Tristan B OrpinSenior VP/Chief Commercial Ofcr |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
ILMN News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page